Healthcare provider profile · identity verified

Daniel C Weaver, M.D.

Family Practice · EDMESTON, NY · NPI 1548391915

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	319	54
Omeprazole	Omeprazole	171	40
Metformin Hcl	Metformin Hcl	159	37
Amlodipine Besylate	Amlodipine Besylate	156	35
Atorvastatin Calcium	Atorvastatin Calcium	154	35
Tamsulosin Hcl	Tamsulosin Hcl	149	32
Gabapentin	Gabapentin	147	29
Losartan Potassium	Losartan Potassium	144	36
Lisinopril	Lisinopril	136	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	20
Hydrochlorothiazide	Hydrochlorothiazide	126	27
Metoprolol Succinate	Metoprolol Succinate	119	29
Pantoprazole Sodium	Pantoprazole Sodium	109	24
Rosuvastatin Calcium	Rosuvastatin Calcium	104	23
Eliquis	Apixaban	102	21
Famotidine	Famotidine	95	17
Metoprolol Tartrate	Metoprolol Tartrate	91	20
Furosemide	Furosemide	85	21
Finasteride	Finasteride	78	16
Progesterone	Progesterone, Micronized	61	13
Clopidogrel	Clopidogrel Bisulfate	60	15
Simvastatin	Simvastatin	59	suppressed
Testosterone Cypionate	Testosterone Cypionate	59	19
Liothyronine Sodium	Liothyronine Sodium	58	13
Glipizide	Glipizide	57	13
Albuterol Sulfate Hfa	Albuterol Sulfate	53	17
Warfarin Sodium	Warfarin Sodium	52	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	13
Estradiol	Estradiol	48	12
Tramadol Hcl	Tramadol Hcl	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	11
Clonazepam	Clonazepam	45	suppressed
Allopurinol	Allopurinol	44	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Lorazepam	Lorazepam	39	11
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Trazodone Hcl	Trazodone Hcl	38	13
Spironolactone	Spironolactone	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	11
Alendronate Sodium	Alendronate Sodium	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	22
Diclofenac Sodium	Diclofenac Sodium	33	17
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Naproxen	Naproxen	29	suppressed
Np Thyroid	Thyroid,pork	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Mupirocin	Mupirocin	26	21
Morphine Sulfate	Morphine Sulfate	25	suppressed
Prednisone	Prednisone	25	14
Sertraline Hcl	Sertraline Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Fentanyl	Fentanyl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Icosapent Ethyl	Icosapent Ethyl	23	suppressed
Amoxicillin	Amoxicillin	22	18
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Ozempic	Semaglutide	19	suppressed
Torsemide	Torsemide	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Montelukast Sodium	Montelukast Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Digoxin	Digoxin	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Xyosted	Testosterone Enanthate	12	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error